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Bone substitutes based on hydroxyapatite (HA) and Bonefill® (BO - inorganic bovine bone) associated 
with poly(lactic-co-glycolic acid) (PLGA) (HA/PLGA and BO/PLGA) were evaluated concerning 
cytotoxicity, genotoxicity and mutagenicity as potential candidates for bone repair. The materials were 
developed and provided by Bionnovation Biomedical Products Ltda. Eluates from these bone substitutes 
were prepared for toxicity evaluations using eukaryotic cell cultures. HA/PLGA was used as a comparison 
for Bonefill®. Cell viability was evaluated by XTT assay and surviving fraction was calculated for 
clonogenic survival. Additionally, tail moment was used to assess genotoxicity (comet assay). The 
frequencies of binucleated cells with micronucleus (FBMN), micronucleus (FMN), nucleoplasmic bridges 
(NPBs), and nuclear buds (NBUDs) were analysed by cytokinesis-block micronucleus assay (CBMN 
assay). Results showed no statistical difference in cell viability compared with negative control (NC) 
The eluates did not promote delayed cytotoxicity whereas the surviving fraction rate for cultured cells 
was similar to NC. Furthermore, no genotoxicity or mutagenicity effects were observed for cultured cells 
with the Bonefill/PLGA and HA/PLGA eluates. In conclusion, the negative cytotoxicity, genotoxicity 
and mutagenicity results indicate that these bone substitutes presented interesting preliminary results as 
potential biomaterials for bone repair.
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INTRODUCTION
Over the years, therapeutic approaches and 
alloplastic materials have been developed which improve 
bone repair/regeneration mainly in tissue engineering. 
However, bone grafts are still used as an alternative 
to support bone repair in traumatic or non-traumatic 
injuries (Suchanek, Yoshimura, 1998; Kaveh et al., 
2010; Dimitriou et al., 2011). The gold standard for 
bone reconstruction is autograft, due to the low rejection 
factor and its osteogenic properties. However, the 
disadvantages of this graft include additional surgery 
and limited donor quantities (Costantino et al., 1991; 
Suchanek, Yoshimura, 1998; Kannana et al., 2014). In 
addition, allografts and xenografts have been used as 
alternatives for bone repair, although they may promote 
rejection, and diseases can be transmitted when not 
properly chemically processed (Suchanek, Yoshimura, 
1998). For these reasons, alternative bone substitutes 
auto, allo and xenografts to replace auto, allo, and 
xeno bone grafts (Saska et al., 2015) which contain 
materials with similar characteristics to bone tissue, 
such as osteoconductive, osteoinductive and osteogenic 
properties for decreasing immunogenic and compatibility 
problems (Saska et al., 2015).
From the materials used for bone repair/regeneration, 
hydroxyapatite (HA) and derived apatite have shown good 
biocompatibility, bioactivity and osteocompatibility 
(Suchanek, Yoshimura, 1998; Shi et al., 2015), as 
well as not stimulating toxic or foreign body giant cell 
reactions (Costantino et al., 1991; Kannana et al., 2014). 
Bioceramics have therefore become an interesting material 
in bone repair/regeneration, in spite of the weak mechanical 
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properties of pure HA ceramics (Suchanek, Yoshimura, 
1998). Due to their bioactivity and reabsorption features, 
they promote direct binding to living tissue and their own 
slow and gradual degradation which is replaced by the 
tissues in which they are implanted (Wang et al., 2005). 
However, metallic, ceramic and polymer materials have 
been combined with HA to improve its mechanical and 
biological properties (Suchanek, Yoshimura, 1998; Shi 
et al., 2015).
Other alloplastic materials, such as synthetic 
polymers, have been used to improve bone replacement. 
One of those, poly(lactic-co-glycolic acid) (PLGA) is 
a biodegradable aliphatic polyester polymer obtained 
from hydroxyl acids (De Lima et al., 2011); it is used in 
several biomedical applications, such as tissue and genetic 
engineering and drug delivery (Cieślik et al., 2009). This 
polymer has the capacity to modulate the mechanical 
properties of others compounds and provide versatility in 
their structure (Saska et al., 2015), and it can be used as 
supporting or stabilizing elements by creating composites 
based on them (Cieślik et al., 2009). The association with 
other compounds provides biocompatibility, bioactivity, 
satisfactory mechanical properties, and osteoconduction, 
which makes them potential materials in regenerative 
medicine therapies (Saska et al., 2015).
A l t h o u g h  x e n o g r a f t s  m a y  i n d u c e  s o m e 
immunogenic and inflammatory reactions depending 
on the host, bovine grafts have been a good option 
for bone regeneration in humans. As their inorganic 
phases are similar to human bone, and if bovine grafts 
are correctly processed, they are a reliable and high 
available source (Galia et al., 2008; Galia et al., 2009). 
Moreover, xenografts have good biocompatibility 
without unfavourable immunologic responses (Rios et 
al., 1996; Araújo et al., 2009).
Engineered nanomaterials have become prevalent 
in our everyday life, raising awareness of nanotoxicology 
to accelerate our understanding of the ill effects that 
different nanomaterials can bring to biological systems 
(Setyawati et al., 2013). In this context, this study aimed 
to evaluate toxicological effects of alloplastic materials 
based on hydroxyapatite and PLGA (HA/PLGA) and 
inorganic bovine bone and PLGA, named Bonefill® 
(Bionnovation Biomedical Products Ltda, Brazil). We 
therefore evaluated the cytotoxicity, genotoxicity and 
mutagenicity of the bone substitutes in block, HA/PLGA 
and Bonefill®, as the biologic safety of medical devices 
form part of the risk management and analysis process, 
and this information also plays an important role in the 
safe use of the biomaterial.
MATERIALS AND METHODS
Materials
The HA/PLGA and Bonefill® block materials were 
provided by Bionnovation Biomedical Products Ltda 
(Brazil), and sterilized by gamma irradiation at dose of 
25 kGy.
Cell culture experiments
Chinese hamster ovary cells (CHO-K1) were 
grown in 1:1 Ham-F10+D-MEM (Sigma®, St. Louis, 
MO) culture medium supplemented with 10 % (v/v) 
fetal bovine serum (FBS) (fetal bovine serum-Cultilab, 
Campinas, Brazil) and kanamycin (1%) (Gibco, Carlsbad, 
CA) at 37 ºC in a 5% CO2 atmosphere. Cells were used 
between the 3rd and 8th passages. CHO cell line has been 
widely used for studies that assess cytotoxicity and 
genotoxicity (Yalkinoglu, Schlehofer, Hausen, 1990) and 
are recommended by The Organization for Economic 
Cooperation and Development (2004) (OECD, 2014) for 
genotoxicity screening.
Eluates from each HA/PLGA and Bonefill® 
(Bonefill/PLGA) block were prepared considering weight 
(0.2 g mL). The materials were immersed in 1:1 Ham-
F10+D-MEM medium (Sigma®) without fetal bovine 
serum (FBS) at 37 ºC for 72 h (Iso, 2008), shaking at 180 
×g in an incubator (New Brunswick Scientific – Excella 
E24 Incubator Shaker Series).
Cytotoxicity tests
XTT assay. These experiments used CHO-K1 cells, 
a Cell Proliferation Kit II (Roche Applied Science), and 
24 h of seeding. CHO-K1 cells (2×104 cells seeded) 
were treated with Bonefill® or HA/PLGA eluates at 
100% concentration for 24 h in 24-well plates. Each well 
containing the respective eluate was supplemented with 
10% FBS. Negative controls (NC) were wells containing 
culture medium supplemented with 10% FBS without 
any eluate (untreated controls), while positive controls 
(PC) were wells containing CHO-K1 cells, treated with 
doxorubicin (3 µg.mL−1) for 24 h (all treatments performed 
in triplicate). After treatment, cultures were washed with 
PBS and fresh medium was added. Subsequently, cultures 
were washed with PBS and 500 µL DMEM without phenol 
red was immediately added, followed by 60 µL of XTT/
electron solution (50:1) (Cell Proliferation Kit II – Roche 
Applied Science). After 3 h reaction, the supernatant was 
transferred to a 96-well culture plate, and absorbance 
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measured by a Microplate Reader (VersaMax, Molecular 
Devices, Sunnyvale,CA) at 492 and 690 nm. Absorbance is 
directly proportional to the number of metabolically active 
cells (viable cells) in each treatment after 24 h of exposure. 
Cell viability was calculated from the absorbance. Three 
independent experiments were conducted.
Clonogenic assay. Clonogenic assay or colony 
formation assay is an in vitro cell survival assay based on 
the ability of a single cell to grow into a colony. The colony 
is defined as consisting of at least 50 cells (Franken et al., 
2006). After 24 h of seeding, CHO-K1 cells (5×104 cells 
seeded) were exposed to Bonefill® or HA/PLGA eluates 
at 100% concentration for 24 h in 24-well plates. Each 
well containing the respective eluate was supplemented 
with 10% FBS. NC were wells containing culture medium 
supplemented with 10% FBS without any eluate, and 
PC were wells containing CHO-K1 cells, treated with 
hydrogen peroxide (80 µmol.L−1) for 10 min. After 
exposure, the cultures were washed with PBS and fresh 
medium added. Exponentially growing cells were seeded 
after treatment at 150 cells per 25 cm2 flasks in duplicate 
for each treatment. The flasks were incubated at 37 ºC, 5% 
CO2, for 7 days without medium exchange. Colonies were 
fixed with methanol:acetic acid:water (1:1:8, v/v/v) and 
stained with 5% Giemsa. The number of colonies counted 
in the negative control group was considered 100%. From 
this, survival fraction (FS) calculations were performed: 
FS = number of colonies counted in each treatment × 
100/Number of colonies observed in the negative control 
group. Three independent experiments were conducted.
Genotoxicity and mutagenicity assays
Comet assay. The alkaline version of the comet 
assay was used according to a previously described 
method (Singh et al., 1988). CHO-K1 cells were seeded 
(5×104 cells seeded) and after 24 h exposed to Bonefill® 
or HA/PLGA eluates at 100% concentration for 24 h 
in 24-well plates. Each well containing an eluate was 
supplemented with 10% FBS. NC were wells with culture 
medium supplemented with 10% FBS without any eluate 
and PC were wells containing CHO-K1 cells treated with 
hydrogen peroxide (80 µmol.L−1) for 10 min (all treatments 
were carried out in duplicate). After exposure, cultures 
were washed with PBS and harvested with trypsin. Five 
hundred microliters of cells in suspension were obtained, 
kept on ice, and protected from light. After centrifugation, 
the pellet was re-suspended in 200 µL of 0.5% (w/v) low 
melting point agarose and the mixture spread onto two 
microscope slides (Knittel, Germany) pre-coated with 
1.5% (w/v) normal melting point agarose (Gibco).
Coverslips were placed over the gel. When the gels had 
solidified, the coverslips were gently removed and the slides 
immersed in cold (4 ºC) lysis solution (1% Triton X-100, 
10% DMSO, 2.5 mmol.L−1 NaCl, 100 mmol.L−1 Na2EDTA, 
100 mmol.L−1 Tris, pH 10) for 24 h. Immediately after this 
step, slides were placed in a horizontal electrophoresis 
unit containing freshly prepared electrophoresis buffer 
(1 mmol.L−1 Na2EDTA, 300 mmol L−1 NaOH, pH > 13). The 
DNA was allowed to unwind for 20 min; electrophoresis 
was then performed at 43V, 308 mA for 25 min. The 
slides were then gently immersed in neutralization buffer 
(0.4 mol.L−1 Tris– HCl, pH 7.5) for 15 min and then fixed 
with ethanol. All steps of the comet assay were conducted 
under subdued light. Three independent experiments were 
conducted. DNA damage was determined blinded regarding 
treatment in 100 nucleoids per slide. Slides were prepared 
in triplicate, stained with ethidium bromide, and screened 
with a fluorescent microscope (ZEISS®, Jena,Thuringia, 
DEU) equipped with a 515–560 nm excitation filter, a 590 
nm barrier filter, and a 40X objective. The level of DNA 
damage was assessed by an image analysis system (TriTek 
CometScore®1.5, 2006, Sumerduck, VA, USA), and 
the percentage of DNA in the tail and Tail Moment were 
obtained for each treatment.
Cytokinesis-blocked micronucleus assay (CBMN). 
CBMN assay for mutagenicity evaluation was performed 
according to a reliable study (Fenech, 2000) with minor 
modifications. CHO-K1 cells (37×104 cells/culture flask) 
were seeded in 25 cm2 culture flasks at 37 ºC, 5% CO2. 
After 24 h of seeding, cells were exposed for 24 h to 
Bonefill® or HA/PLGA eluates at 100% concentration. 
Each culture flask containing an eluate was supplemented 
with 10% FBS. NC were culture flasks containing culture 
medium supplemented with 10% FBS without any eluate 
(untreated controls), and PC were culture flasks containing 
CHO-K1 cells treated with doxorubicin (0.3 µg.mL−1) for 
4 h. Cytochalasin-B (CytB) was added to the CHO-K1 
cultures at a final concentration of 5 µg.mL−1 and left for 
24 h. After treatments, the cultures were washed with 
PBS, trypsinized and centrifuged for 5 min at 406×g. The 
pellet was then resuspended in cold hypotonic solution 
(0.3% KCl, w/v) for 3 min. Cells were fixed twice with 
methanol:glacial acetic acid (3:1, v/v) and with four drops 
of formaldehyde, and then carefully homogenized with a 
Pasteur pipette. The cell suspensions were dripped on to 
a slide with a film of distilled water at 4 ºC. Slides were 
stained with 5% Giemsa solution diluted in phosphate 
buffer (Na2HPO4 0.06 mol.L−1, KH2PO4 0.06 mol.L−1 – 
pH 6.8) for 7 min, washed with distilled water, air dried, 
and examined by light microscopy (400× magnification). 
Three independent experiments were conducted.
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Five hundred (500) viable cells were scored to 
determine the frequency of cells with 1, 2, 3, or 4 nuclei. 
The nuclear division index (NDI) was calculated using 
the formula: [NDI = M1 + 2(M2) + 3(M3) + 4 (M4)/N], 
where M1–M4 represents the number of cells with 1–4 
nuclei, respectively, and N is the total number of viable 
cells scored (Eastmond, Tucker, 1989; Fenech, 2000). 
The frequency of binucleated cells with micronuclei 
(MNBCF), total frequency of micronuclei (MF), 
frequency of nucleoplasmic bridges (FNPBs) and the 
frequency of nuclear buds (NBUDs) were scored in 
1000 binucleated cells for each treatment. The criteria 
used for identifying micronuclei were based on Fenech 
(2000).
Statistical analysis
At least 3 experiments were conducted for each 
analysed parameter. The experimental results were 
expressed as mean and standard error (SE). The Shapiro-
Wilk test was used to assess data normality and Levene’s 
test for data homogeneity. In view of the results, parametric 
tests were utilized. For XTT, Clonogenic Survival, Comet, 
and CBMN assays, one-way ANOVA test followed by 
Tukey’s test were applied to the data. In addition, data 
from treated groups were compared with negative controls 
(Dunnett’s test). The non-parametric Kruskal-Wallis test 
was applied for NDI (CBMN), followed by Dunn’s test. 
Graphpad Prism 5.01 was used to perform the statistical 
tests. Differences were considered statistically significant 
when p<0.05.
RESULTS AND DISCUSSION
Although there is some published research on 
the toxicity of PLGA, HA and xenograft from bovine 
bone, inasmuch as a chemical modification takes place, 
toxicity potential regarding these materials requires 
investigation. Hence, toxicity data obtained by these 
studies may determine whether the material is safe for 
medical implants (Galia et al., 2008). Safety assessments 
of medical materials can be conducted by toxicological 
guidelines recommended by the International Organization 
of Standardization (ISO 10993-1/EN 30993-1). Depending 
on the type and extent of contact of a material with the 
patient, a standardized battery of biological safety tests 
are suggested by the ISO (Scarel-Caminaga et al., 2014).
Considering that the materials investigated in this 
study are potential candidates for bone substitute as 
alloplastic block grafts requiring long-term contact with 
host fluids and tissues, some cytotoxicity and genotoxicity 
assessments are required under ISO guidance (Scarel-
Caminaga et al., 2014).
Cytotoxicity results are shown in Figure 1 (XTT cell 
viability assay). Cell viability is related to absorbance. 
Negative control corresponded to 100% cell viability. 
The results obtained for NC and HA/PLGA and Bonefill® 
eluates did not significantly differ (p>0.05, Dunnett’s test), 
indicating that the materials did not affect cell viability.
Literature describes several assays that can be 
used to determine toxicity in polymeric nanostructured 
systems, including assays involving cell viability analyses 
FIGURE 1 - XTT assay in CHO-K1 (Cell viability). Cells treated with 100% concentration HA/PLGA and Bonefill® eluates. NC: 
negative control; PC: positive control. NC represents 100% cell viability. Columns = mean of cell viability (%); bars = Standard 
error. *** = p<0.0001 compared to NC; Dunnett’s test.
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of mammalian cells, such as the tetrazolium salt reduction 
assay (XTT), MTT assay and genotoxicity assays (Cieślik 
et al., 2009). Therefore, the XTT assay was used to evaluate 
cell viability after exposure to eluates from HA/PLGA and 
Bonefill® materials. This assay is based on cell metabolic 
activity where the reduction of yellow tetrazolium salt 
to orange formazan dye only occurs in viable cells by 
mitochondrial dehydrogenases; this can be measured 
by absorbance. It is important to bear in mind that the 
XTT assay aims to demonstrate immediate cytotoxic 
effect on cultured cells, whereas the clonogenic survival 
assay shows whether other damage has occurred to cells 
that interfere with or stop their proliferative capacity at 
a later time (Sumantran et al., 2007). The results of this 
study showed the absence of cytotoxic effects from HA/
PLGA and Bonefill® eluates, which are in accordance with 
literature demonstrating HA, bovine bone, and PLGA as 
biocompatible materials (Galia et al., 2008; Cieślik et al., 
2009; Trif et al., 2015). PLGA nanoparticles associated 
with polyethylene glycol (PEG) and poly L-lysine (PLL) 
(PEG-PLL-PLGA) have demonstrated low cytotoxicity 
by MTT assay (Guo et al., 2015).
Furthermore, different concentrations of PLGA 
nanoparticles have shown no cytotoxicity to fibroblasts 
(3T3) by MTT assay (De Lima et al., 2011). In contrast, 
high concentrations (5,000 µg.mL-1) of PLGA nanoparticles 
induced moderate cytotoxicity in Madin–Darby bovine 
kidney (MDBK) cells (Trif et al., 2015). However, the 
same concentration did not induce a cytotoxic effect 
in human colorectal adenocarcinoma (Colo 205) cells. 
Also, no cytotoxicity was seen from PLGA and HA/
PLGA composites by the lactate dehydrogenase (LDH) 
test (Cieślik et al., 2009). Additionally, lyophilized 
bovine bone prepared on a semi-industrial scale showed 
no cytotoxicity potential by the agar diffusion test (Galia 
et al., 2008). Studies have verified that even with a high 
particle surface area, particles concentrations between 
5.4 and 540 µg/mL are incapable of inducing cell toxicity 
(Semete et al., 2010; De Lima et al., 2011), agreeing with 
previously presented explanations.
The surviving fraction obtained by clonogenic 
survival assay revealed no statistical difference with NC 
(p>0.05, Dunnett’s test; Figure 2).
The clonogenic assay evaluated whether the material 
interferes in mitotic replication of CHO-K1 cells, since 
only mitotically viable cells can produce progenitor cells. 
We verified that HA/PLGA and Bonefill® eluate did not 
interfere in cell survival or the proliferation capacity of a 
single cell. Increasing eluate HA concentration was shown 
to increase cytotoxic effects by inhibiting cell-colony 
formation (Jantová et al., 2008).
The general cytotoxicity results revealed that HA/
PLGA and Bonefill® were not cytotoxic, showing no 
disturbance in mitotic cell replication.
Tail moment evaluation verified that neither HA/
PLGA or Bonefill® promoted genotoxic effects (p>0.05, 
Dunnett’s test; Figure 3).
The alkaline version of Comet assay can detect 
DNA double-strand breaks, alkali-labile sites, and single-
strand breaks associated with incomplete excision repair 
sites (Tice et al., 2000; Araújo et al., 2009). Tail moment 
evaluation verified that HA/PLGA and Bonefill® bone 
substitutes did not promote genotoxic effects. The concept 
of tail moment (calculated as the product of tail length 
and total DNA fraction in the tail) is a measurement 
of DNA migration. This method incorporates relative 
FIGURE 2 - Clonogenic survival assay in CHO-K1. Cells treated with 100% concentration HA/PLGA and Bonefill® eluates. NC: 
negative control; PC: positive control. NC represents 100% survival fraction. Columns = mean of survival fraction (%); bars = 
Standard error. *** = p<0.0001 compared to NC; Dunnett’s test.
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measurements of both the smallest detectable size of 
migrating DNA (reflected by comet tail length) and 
the number of broken pieces of DNA (represented 
by the staining intensity of DNA in the tail) (Liao, 
Mcnutt, Zhu, 2009). The study of DNA damage at the 
chromosome level is an essential part of genetic toxicology 
whereas chromosomal mutation is an important event in 
carcinogenesis. Studies investigating HA toxicity have 
shown that it does not induce genotoxic effects (Kannana 
et al., 2014), however comet assay showed increasing HA 
concentrations (10% to 100%; v/v) induced DNA damage 
(between 13.1 and 14.2%), which was dose-dependent 
(Jantová et al., 2008).
Table I shows mutagenicity assay results of: nuclear 
division index (NDI), the frequency of binucleated cells 
with micronuclei (BCMN), and micronucleus (MN), 
nucleoplasmic bridge (NPB), nuclear bud (NBUD) 
frequencies.
NDI was similar between groups (p>0.05; Kruskal 
Wallis’s), except for PC and Bonefill® (p<0.05; Kruskal 
Wallis’s). Nuclear Division Index (NDI) is a marker of 
cell proliferation in cultures and is considered a measure 
of general cytotoxicity (Eastmond, Tucker, 1989; Fenech, 
2000; Ionescu et al., 2011). There may be an induction 
of mitotic delay which, by not allowing the repair of 
genotoxic lesions, will modify the number of cells entering 
mitosis and modify the proportion of mono-/bi-/tri- and 
tetranucleated cells (Ionescu et al., 2011). Thus, lower 
NDI can signify fewer cell divisions. There is also the 
hypothesis of a clastogenic effect from mutagens with 
an aneugenic action, inducing some degree of cell cycle 
blockade. Therefore, more cells will not divide and NDI 
will again be low. There was no significant difference 
in NDI between NC and both Bonefill® or HA/PLGA 
materials, indicating that these materials did not induce 
CHO-K1 nuclear division arrest. Therefore, Bonefill® and 
HA/PLGA did not decreased cell division.
HA/PLGA and Bonefill® were not mutagenic, as 
only PC was statistically higher than NC for FBCMN, 
FMN, and FNBUD. In FNPB, only Bonefill® was 
statistically lower than NC emphasizing that this material 
did not induce nucleoplasmic bridges.
TABLE I - CBMN assay in CHO-K1. Mean and standard error of nuclear division index (NDI), frequency of binucleated cells with 
micronucleus (FBCMN), frequency of micronuclei (FMN), frequency of nucleoplasmic bridges (FNPBs) and frequency of nuclear 
buds (NBUDs), in 1000 binucleated cell for each treatment. Cells treated with 100% concentration of HA/PLGA and Boneffil® 
eluates. NC: negative control; PC: positive control; *p<0.05 compared to NC group (Dunnett’s test); a,b = p<0.05 (Kruskal-Wallis’s 
test). 
TREATMENT NDI Mean ± SE
FBCMN 
Mean ± SE
FMN 
Mean ± SE
FNPBs 
Mean ± SE
FNBUDs 
Mean ± SE
NC 1.914± 0.002 16.33 ±0.298 21.67±1.075 5.33±0.789 16.57±2.024
PC 1.754±0.005a 91.67±1.814* 143.67±5.873* 40.6±1.300* 101.29±7.928*
HA/PLGA 1.977±0.006 15.33±1.193 20.33 ± 1.578 4.33±0.298 11.86±2.436
Bonefill® 2.032±0.013b 11.67±1.660 12.67±1.193 2.33±0.298* 13.71±1.723
FIGURE 3 - Comet assay in CHO-K1. Cells treat with 100% concentration HA/PLGA and Bonefill® eluates. NC: negative control; 
PC: positive control. Columns = mean of tail moment; bars = Standard error. *** = p<0.0001 compared to NC; Dunnett’s test.
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The micronucleus assay (or cytokinesis-blocked 
micronucleus) has emerged as one of the preferred methods 
for assessing chromosome damage because it enables both 
chromosome loss and chromosome breakage to be reliably 
measured (Fenech, 2000). Although using a different 
method, the Salmonella Typhimurium bacterial test, 
Jantová et al., (2008) also observed no mutagenic effect in 
100% HA-concentration eluates. Therefore, HA was not 
mutagenic, even at high concentration, by two different 
reliable tests (CBMN and bacterial mutagenicity test).
Our study showed that 100% HA/PLGA eluate 
concentration (v/v) did not promote cytotoxic, genotoxic, 
or mutagenic effects. This is in agreement with Cieślik et 
al. (2009) who demonstrated that an HA/PLGA composite 
was fully biocompatible and the bone defects were 
fully repaired after 48 weeks. They concluded that this 
composite did not induce toxic effects on bone-forming 
cells.
Cyto- and genotoxicity effects on materials prepared 
with PLGA nanoparticles require further study, even 
though this polymer is one of the most widely used in 
the preparation of polymer nanoparticles, mainly for 
pharmaceutical and medical processes. Studies concerning 
the impact of these nanostructures on living organisms 
and the environment are therefore needed so that the 
safety of these nanosystems can be assessed before they 
become even more widely commercialized (De Lima et 
al., 2011). For example, the aforementioned PEG-PLL-
PLGA showed no blood toxicity and mutagenicity by MN 
(Guo et al., 2015). Positively charged PLGA nanoparticles 
led to chromosomal aberrations without primary DNA 
damage in human bronchial epithelial cells (Platel et 
al., 2016). Human peripheral blood mononuclear cell 
cultures treated with PLGA-PEO nanoparticles revealed 
no increase in the number of micronucleated binucleated 
cells (Tulinska et al., 2015). On the other hand, PLGA-
PEO lead to a weak but significant increase in the level 
of MN in TK6 human B-lymphoblastoid cells, which did 
not induce DNA strand-breaks (detected by comet assay), 
nor was it cytotoxic (measured by relative cell growth 
activity and cytokinesis-block proliferation index (CBPI)) 
(Kazimirova et al., 2012).
Previous studies have shown that HA/PLGA 
composites not only promote adequate bone regeneration 
(Galia et al., 2008), but also do not induce cytotoxicity 
(Galia et al., 2008; Cieślik et al., 2009; Kannana et al., 
2014), mutagenicity (Kazimirova et al., 2012; Kannana et 
al., 2014), or genotoxicity (Cieślik et al., 2009; Kannana 
et al., 2014), which corroborate with the results of this 
study. In this way, HA/PLGA results were used as a bench 
mark to evaluate whether Bonefill® could have the similar 
toxicity profile to that of HA/PLGA. Both materials 
demonstrated similar results - not inducing cytotoxic, 
genotoxic, or mutagenic effects in CHO-K1 cells.
CONCLUSION
Considering the negative cytotoxicity, genotoxicity 
and mutagenicity results found for HA/PLGA and 
Bonefill®, it was concluded that these bone substitutes 
presented interesting preliminary results as potential 
biomaterials for bone repair.
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